Page 54 - AN-1-1
P. 54

Advanced Neurology                                                          EPAC2 null leads to tauopathy



            somatodendritic compartment of CA1 and CA3 neurons in   using a previously reported protocol . In the RIPA
                                                                                               [20]
            EPAC2  mice (Figure 1L-O). To exclude the involvement   fraction (soluble tau), only slight increases in pT231 and
                 −/−
            of developmental factors in tau phosphorylation, we   pT205/pT231  were  found  in  the  EPAC2   mice  on  the
                                                                                                 −/−
            transfected short hairpin RNA (shRNA) toward mouse   6  and 18  months, respectively (Figure 3A-D). However,
                                                                th
                                                                       th
            EPAC2 into N2a cells and examined tau phosphorylation at   immunoactivity toward phosphorylated tau (pT205,
            these sites. In line with our in vivo data, silencing of EPAC2   pT231, pS396, and pS404) in the 70% FA fraction (insoluble
            led to the hyperphosphorylation of tau at multiple epitopes   tau) was dramatically increased in EPAC2  mice,
                                                                                                      −/−
            (Figure  1J  and  K). We next examined whether EPAC2   especially in the 18-month-old mice (Figure 3E-H). Thus,
            expression was reduced in the transgenic AD mouse model.   loss of EPAC2 decreases the solubility of tau and promotes
            By RT-PCR and Western blot, both the mRNA and protein   its aggregation. Because the aggregation of tau is one of
            levels of EPAC2 were reduced in the hippocampus of Tg2576   the key steps in the formation of NFTs, we then performed
            mice on the 12   month (Figure  1A-D). Moreover, the   Bielschowsky silver staining to visualize the morphology
                         th
            levels of tau hyperphosphorylation in the hippocampus of   of  neurons.  We  found  that  the  cortical  neurons  in  the
            EPAC2  mice gradually increased with age (Figure 2A-G).   EPAC2  mice (9   month) displayed more argyrophilic
                 −/−
                                                                             th
                                                                     −/−
            Thus, the downregulation of EPAC2 in AD can induce the   aggregates and more dystrophic neurites than the control
            age-dependent hyperphosphorylation of tau in the brain.  mice (Figure 3I). Thus, the absence of EPAC2 leads to tau
                                                               aggregation and somatodendritic abnormalities.
            3.2. Downregulation of EPAC2 induces tau
            insolubility and somatodendritic abnormalities     3.3. Downregulation of EPAC2 activates CDK5 by
            The hyperphosphorylation of tau induces conformational   increasing calpain activity
            changes that result in the aggregation of the protein .   An imbalance of tau kinases and phosphatases is implicated
                                                        [21]
            Therefore, we next examined whether the absence of   in the abnormal tau hyperphosphorylation in AD . We,
                                                                                                       [22]
            EPAC2 impacts the soluble and insoluble pools of tau   therefore, examined the levels and activities of PP2a, ERK,
            A                                       B                          C









                                                                               E
                                                    D










                                                    F                          G












            Figure 2. Age-dependent tau hyperphosphorylation in EPAC2  mice. (A) The hippocampal homogenates were prepared from EPAC2  mice and wild-
                                                                                                  −/−
                                                    −/−
                                  rd
                    +/+
            type EPAC2  littermates on the 3 , 6 , 9 , and 18  months. The relative levels of EPAC2, total tau (TAU-46), non-phosphorylated tau (TAU-1), and
                                             th
                                       th
                                     th
            phosphorylated tau at Thr205 (pT205), Thr231 (pT231), Ser396 (pS396), and Ser404 (pS404) sites were examined by Western blot. (B–G) Quantification
            of the immunoreactivities of the different antibodies indicated in (A); n = 3, *P < 0.05.
            Volume 1 Issue 1 (2022)                         5                         https://doi.org/10.36922/an.v1i1.8
   49   50   51   52   53   54   55   56   57   58   59